Nearly 90% of Takeda Pharmaceutical shareholders have voted to back a $59 billion purchase of Irish drugmaker Shire, which trades on the London Stock Exchange. The deal is the largest offshore acquisition by a Japanese company.
Takeda shareholders approve $59B takeover of Shire
Sign up for AABB SmartBrief
News about transfusion and cellular therapies
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.